CareMax, Inc.

CareMax, Inc., a Delaware corporation (the “Company”), is unable to file, without unreasonable effort or expense, its Quarterly Report on Form 10-Q for the fiscal quarter ended September 30, 2024 (the “Form 10-Q”) within the prescribed time period. As previously disclosed, the Company continues to undergo efforts to reduce operating expenses and pursue various equity and debt refinancing and other strategic alternatives, including the sale of certain assets. Due to the considerable time and resources the Company is devoting to such efforts, the Company does not have the funds or personnel necessary to file the Form 10-Q within the extension period provided by Rule 12b-25 under the Securities Exchange Act of 1934, as amended. If the Company is unable to successfully implement its plans or receive adequate relief from its creditors and lessors, the Company is likely to restructure under Chapter 11 of the US Bankruptcy Code

CareMax, Inc., a Delaware corporation (the “Company”), is filing this Notification of Late Filing on Form 12b-25 with respect to its Annual Report on Form 10-K for its fiscal year ended December 31, 2023 (the “Form 10-K”). As the Company was preparing the financial statements for the Form 10-K, it determined that it was not in compliance with a financial covenant in its credit agreement for the test period ended December 31, 2023. As a result of this determination, management devoted considerable time and effort to negotiating a waiver under the credit agreement, which impacted the Company’s ability to complete the Form 10-K without unreasonable effort or expense. The Company received the required waivers from the lenders under its credit facility on March 15, 2024, but was unable to complete its filing before the close of business on March 15, 2024. The Form 10-K was filed on March 18, 2024 prior to the filing of this Notification of Late Filing on Form 12b-25

CareMax, Inc. (the “Company”) is filing this Notification of Late Filing on Form 12b-25 with respect to its Annual Report on Form 10-K for its fiscal year ended December 31, 2022 (the “2022 Annual Report”). The delay is the result of the Company reevaluating the balance sheet classification of the non-cash prepaid asset (the “Prepaid Asset”) associated with the equity consideration issued to the Company’s real estate advisor in July 2021, as disclosed in the Company’s Current Report on Form 8-K filed on March 16, 2023 (the “Current Report”). The Prepaid Asset was previously classified as short-term in other current assets. The Company concluded that the majority of the Prepaid Asset should instead be classified as long-term within other assets (the “Misclassification”). The Audit Committee of the Board of Directors of the Company, after discussions with the Company’s management and WithumSmith+Brown, PC, the Company’s independent registered accounting firm for the year ended December 31, 2021, determined that certain of its financial statements should no longer be relied upon. As disclosed in the Current Report, the Company intends to restate such financial statements. As a result, the Company was unable to complete the filing of the 2022 Annual Report within the prescribed time period without unreasonable effort or expense because the Company requires additional time to complete its financial statement preparation. As previously disclosed, in connection with the preparation and audit of the Company’s financial statements for the year ended December 31, 2021, certain material weaknesses were identified in the Company’ internal control over financial reporting. As of the date of the filing of this Notification of Late Filing on Form 12b-25, management of the Company has determined that such material weaknesses had not been remediated as of December 31, 2022

CareMax, Inc. (the “Company”) plans to file its Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2021 (the “Quarterly Report”) with the Securities and Exchange Commission (“SEC”) as soon as practicable and within the five calendar day period provided by Rule 12b-25 for delayed filings. As previously disclosed, on June 8, 2021, the Company completed its business combination with CareMax Medical Group, L.L.C., a Florida limited liability company (“CMG”), and IMC Medical Group Holdings, LLC, a Delaware limited liability company (“IMC”), whereby the Company acquired 100% of the equity interests of CMG and IMC, with CMG and IMC becoming wholly owned subsidiaries of the Company (the “Business Combination”), and the Company simultaneously completed a financing transaction involving the sale of an aggregate of 41,000,000 shares of the Company’s Class A common stock (the “PIPE Investments” and together with the Business Combination, the “Business Combination Transactions”). The Business Combination was accounted for as a reverse recapitalization by which CMG issued equity for the net assets of the Company accompanied by a recapitalization (the “Reverse Recapitalization”). Further, CMG was determined to be the accounting acquirer in the acquisition of IMC (the “IMC Acquisition”), which was accounted for using the acquisition method of accounting. Additionally, as previously disclosed, on June 18, 2021, IMC completed the acquisition of 100% of the issued and outstanding equity interests of Senior Medical Associates, LLC, a Florida limited liability company, and Stallion Medical Management, LLC, a Florida limited liability company (“the SMA Acquisition”)

Deerfield Healthcare Technology Acquisitions Corp. (the “Company”) has determined that it is unable, without unreasonable effort or expense, to file its Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 2021 (the “Q1 2021 Form 10-Q”) by the prescribed due date for the reasons described below. On April 12, 2021, the Staff of the U.S. Securities and Exchange Commission (the “SEC”) issued the “Staff Statement on Accounting and Reporting Considerations for Warrants Issued by Special Purpose Acquisition Companies (“SPACs”)” (the “SEC Statement”), which clarified guidance for all SPACs regarding the accounting and reporting for their warrants. Following review of the SEC Statement, the Company reevaluated the accounting treatment of its public warrants and private placement warrants (collectively, the “Warrants”) as equity, and concluded that, based on the SEC Statement, the Warrants should be, and should previously have been, classified as a liability measured at fair value, with non-cash fair value adjustments recorded in earnings at each reporting period. As a result of the foregoing, on April 28, 2021, the Company filed a Form 10-K/A with the SEC restating its financial statements for the affected periods because of a misapplication of the guidance around accounting for the Warrants (the “Restatement”). Due to the considerable time and dedication of resources by the Company and its external advisors required to complete the Restatement, the Company was unable to file its Quarterly Report by its prescribed due date without unreasonable effort or expense. The Company does, however, expect to file such report within five calendar days of May 17, 2021